Literature DB >> 7764721

Effect of growth rate on stability and gene expression of recombinant plasmids during continuous and high cell density cultivation of Escherichia coli TG1.

K Hellmuth1, D J Korz, E A Sanders, W D Deckwer.   

Abstract

Continuous and fed-batch cultures of recombinant Escherichia coli TG1 were carried out in order to study plasmid stability and recombinant product formation at different specific growth rates. The aprotinin::beta-galactosidase gene (Ap::lacZ) was placed under the control of two different promoter/repressor systems, the PLac/lacI (pPLac8) and the lambda PL/cIts857 (pPL6) system. The chemically (0.5 mM IPTG) induced gene expression exhibited higher product activity and plasmid stability than the thermally (40 degrees C) induced expression. In fed-batch cultivations with the more stable E. coli TG1(pPLac8) a special feeding strategy allowed bacterial growth with a constant growth rate mu for several hours up to high cell densities. The cloned gene product activity was noticeably effected by the specific growth rate and the cell density at the moment of induction. In particular, the enzyme activities passed a pronounced maximum value in dependence of the set growth rate. The results indicate that fed-batch cultivation strategies are well suited to produce recombinant gene products.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7764721     DOI: 10.1016/0168-1656(94)90215-1

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  13 in total

1.  High-level production of human leptin by fed-batch cultivation of recombinant Escherichia coli and its purification.

Authors:  K J Jeong; S Y Lee
Journal:  Appl Environ Microbiol       Date:  1999-07       Impact factor: 4.792

2.  A recombinant vaccine against hydatidosis: production of the antigen in Escherichia coli.

Authors:  Daniel Manderson; Robert Dempster; Yusuf Chisti
Journal:  J Ind Microbiol Biotechnol       Date:  2005-09-30       Impact factor: 3.346

3.  An alkane-responsive expression system for the production of fine chemicals

Authors: 
Journal:  Appl Environ Microbiol       Date:  1999-06       Impact factor: 4.792

4.  Recombinant protein production in an Escherichia coli reduced genome strain.

Authors:  Shamik S Sharma; Frederick R Blattner; Sarah W Harcum
Journal:  Metab Eng       Date:  2006-10-21       Impact factor: 9.783

5.  Novel approach of high cell density recombinant bioprocess development: optimisation and scale-up from microliter to pilot scales while maintaining the fed-batch cultivation mode of E. coli cultures.

Authors:  Juozas Siurkus; Johanna Panula-Perälä; Uwe Horn; Mario Kraft; Renata Rimseliene; Peter Neubauer
Journal:  Microb Cell Fact       Date:  2010-05-20       Impact factor: 5.328

6.  Generation of human monoclonal antibodies against Propionibacterium acnes by applying the phage display method to human peripheral blood mononuclear cells immunized in vitro.

Authors:  Yeon Suk Jung; Shin-Ei Matsumoto; Yoshinori Katakura; Makiko Yamashita; Kosuke Tomimatsu; Shigeru Kabayama; Kiichiro Teruya; Sanetaka Shirahata
Journal:  Cytotechnology       Date:  2008-02-22       Impact factor: 2.058

7.  Maximizing Production of Human Interferon-γ in HCDC of Recombinant E. coli.

Authors:  Valiollah Babaeipour; Seyed Abbas Shojaosadati; Nader Maghsoudi
Journal:  Iran J Pharm Res       Date:  2013       Impact factor: 1.696

8.  Characterisation of the Escherichia coli membrane structure and function during fedbatch cultivation.

Authors:  Atefeh Shokri; Gen Larsson
Journal:  Microb Cell Fact       Date:  2004-07-28       Impact factor: 5.328

9.  High cell density media for Escherichia coli are generally designed for aerobic cultivations - consequences for large-scale bioprocesses and shake flask cultures.

Authors:  Jaakko Soini; Kaisa Ukkonen; Peter Neubauer
Journal:  Microb Cell Fact       Date:  2008-08-07       Impact factor: 5.328

10.  The interrelationship between promoter strength, gene expression, and growth rate.

Authors:  Matthew S Bienick; Katherine W Young; Justin R Klesmith; Emily E Detwiler; Kyle J Tomek; Timothy A Whitehead
Journal:  PLoS One       Date:  2014-10-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.